KR930017907A - β-락탐 화합물에 이용하기 위한 에스테르 절단방법 - Google Patents

β-락탐 화합물에 이용하기 위한 에스테르 절단방법 Download PDF

Info

Publication number
KR930017907A
KR930017907A KR1019930002043A KR930002043A KR930017907A KR 930017907 A KR930017907 A KR 930017907A KR 1019930002043 A KR1019930002043 A KR 1019930002043A KR 930002043 A KR930002043 A KR 930002043A KR 930017907 A KR930017907 A KR 930017907A
Authority
KR
South Korea
Prior art keywords
alkyl
substituted
group
phenyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019930002043A
Other languages
English (en)
Korean (ko)
Inventor
웨인 피셔 잭
린 토마스 크리스티나
Original Assignee
리로이 휘테커
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리로이 휘테커, 일라이 릴리 앤드 캄파니 filed Critical 리로이 휘테커
Publication of KR930017907A publication Critical patent/KR930017907A/ko
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/02Preparation
    • C07D463/06Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019930002043A 1992-02-18 1993-02-12 β-락탐 화합물에 이용하기 위한 에스테르 절단방법 Ceased KR930017907A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/836,640 US5302711A (en) 1992-02-18 1992-02-18 Ester cleavage process for use with β-lactams
US836,640 1992-02-18

Publications (1)

Publication Number Publication Date
KR930017907A true KR930017907A (ko) 1993-09-20

Family

ID=25272395

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930002043A Ceased KR930017907A (ko) 1992-02-18 1993-02-12 β-락탐 화합물에 이용하기 위한 에스테르 절단방법

Country Status (10)

Country Link
US (1) US5302711A (enExample)
EP (1) EP0557035A3 (enExample)
JP (1) JPH05286971A (enExample)
KR (1) KR930017907A (enExample)
BR (1) BR9300542A (enExample)
CA (1) CA2089540A1 (enExample)
HU (1) HUT64351A (enExample)
IL (1) IL104699A0 (enExample)
MX (1) MX9300761A (enExample)
TW (1) TW232694B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2379650C (en) 1999-07-30 2008-09-02 Eisai Co., Ltd. Process for producing a basic antibiotic inorganic acid salt, and oxalate intermediate
CN103588790A (zh) * 2013-11-29 2014-02-19 中国科学院长春应用化学研究所 7-氨基-3-氯-3-头孢-4-羧酸-对硝基苄基酯的制备方法
CN106866704B (zh) * 2017-02-08 2019-06-14 河北科技大学 催化氢化脱除对硝基苄酯以制备7-acca的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1546757A (en) * 1975-04-10 1979-05-31 Lilly Industries Ltd Crystalline cephalosporin salts
JPS52106891A (en) * 1976-03-03 1977-09-07 Shionogi & Co Ltd Removal of carboxyl protecting group
DE2725519A1 (de) * 1977-06-06 1978-12-21 Shionogi & Co Verfahren zur herstellung freier carbonsaeuren durch esterspaltung
IL72412A (en) * 1983-07-22 1988-05-31 Lilly Co Eli Deesterification of beta-lactam antibiotic esters
ATE138664T1 (de) * 1985-08-12 1996-06-15 Upjohn Co Umwandlung des cephalosporin-hydrohalid-salzes zu einem alkalimetallsalz
EP0263901A1 (en) * 1986-10-08 1988-04-20 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
DK0395219T3 (da) * 1989-03-30 1999-02-15 Pfizer Cephalosporiner og deres homologer, fremgangsmåde til deres fremstilling og farmaceutiske præparater
US5043439A (en) * 1990-03-08 1991-08-27 Bristol-Myers Squibb Company Process for production of cephalosporins
US5095107A (en) * 1990-11-05 1992-03-10 Eli Lilly And Company Process for cleavage of esters during the production of cephalosporins

Also Published As

Publication number Publication date
EP0557035A3 (en) 1993-12-01
EP0557035A2 (en) 1993-08-25
HU9300384D0 (en) 1993-04-28
TW232694B (enExample) 1994-10-21
US5302711A (en) 1994-04-12
BR9300542A (pt) 1993-08-24
JPH05286971A (ja) 1993-11-02
IL104699A0 (en) 1993-06-10
CA2089540A1 (en) 1993-08-19
HUT64351A (en) 1993-12-28
MX9300761A (es) 1993-09-01

Similar Documents

Publication Publication Date Title
IE832654L (en) ß-LACTAM COMPOUNDS
IE802174L (en) Penicillin compounds
MY131501A (en) Process for the prepration of clavulanic acid
JPS559058A (en) 1-(3-mercapto-2-methylpropanoyl)prolyl amino acid derivative
HU9402218D0 (en) Pyridinecarboximidamide compounds, pharmaceutical compositions containing them and process for producing them
IE43840L (en) Clavulanic acid derivatives
HUT60924A (en) Process for producing composition in the form of emulsion or solution and comprising immunosuppressing compound
KR880012604A (ko) (1r,5s,6s )-2-치환 티오-6[(r)-1-히드록시에틸]-1-메틸-카바페넴-3-카복실산 유도체
ES8300774A1 (es) Un procedimiento para preparar nuevos compuestos de cefem
IE43519L (en) Benzimidazole-2-carbamates
IE891242L (en) Process for optically active 3-(methane-sulfonyloxy)thiolane¹and analogs
KR930017907A (ko) β-락탐 화합물에 이용하기 위한 에스테르 절단방법
DE3381734D1 (de) Thiazolylessigsaeure-derivate und verfahren zu deren herstellung.
HK47993A (en) 7-beta-(2-(amino-4-thiazolyl)-2-alkenoylamino)-3-cephem-4-carboxylic acid ester derivatives
IE832310L (en) Vinylthioacetamido oxacephalosporin derivatives
IE822917L (en) Optically active penems
ES2000907A6 (es) Procedimiento de preparar compuestos 2-oxaisocefen microbiologicamente activos
KR840007232A (ko) 헤테로싸이클릴 화합물의 제조방법
IE852246L (en) Penicillins
EP0003415A3 (en) Beta-lactam compounds, processes for their preparation,compositions containing them and intermediates of use in their preparation
ES8200687A1 (es) Un procedimiento para la preparacion de nuevos compuestos amidicos de penicilina
IE811734L (en) Making acylazo compounds. n-substituted-2-pyridylindoles
DE3061435D1 (en) Process for the preparation of 5-(2,2,2,-trihalogen-ethyl)-dialkyl-tetrahydrofuran-2-ones
AU565926B2 (en) 6-(1-acyl-1-hydroxy methyl) penicillanic acid derivatives
JPS5589257A (en) New easily-absorbable sulfur-containing prodrug of non- steroidal antiphlogistic, and their drug compositions

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19930212

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19980211

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19930212

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19991129

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20000223

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19991129

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I